Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Weight loss products (4)
- Safety monitoring and information (123)
- Compliance and enforcement (33)
- Import and export (30)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
17 result(s) found, displaying 1 to 17
-
Safety alertsTGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.
-
Market actionsStryker is conducting a Critical Product Correction of Pad-Paks used with the HeartSine samaritan Public Access Defibrillator (PAD), with an expiry date range between 17 April 2025 to 01 August 2029.
-
Safety alertsConsumers and health professionals should be aware that examples of counterfeit products have been stopped at the Australian border. These tablets may pose a serious risk to your health and should not be used.
-
Safety alertsConsumers and health professionals should be aware that examples of substandard Fitaro semaglutide pre-filled syringes have been stopped at the Australian border.
-
Safety alertsFurther examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.
-
Safety alertsGold Max Blue capsules pose a serious risk to your health and should not be taken.
-
Safety alertsDynamint X tablets pose a serious risk to your health and should not be taken.
-
Safety alertsMAXMAN tablets pose a serious risk to your health and should not be taken.
-
Safety alertsConsumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
-
Safety alertsDark Horse Capsules pose a serious risk to your health and should not be taken.
-
Safety alertsThe product tested is not listed in the ARTG and has not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation.
-
Safety alertsYing Da Wang tablets pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
-
Safety alertsBigger Longer More Time More Sperms capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sildenafil, which may interact with some prescription drugs. This may lower your blood pressure to dangerous levels.
-
Safety alertsLi Da Daidaihua capsules pose a serious risk to your health and should not be taken. They contain the undeclared substance sibutramine. This increases the risk of cardiac events and stroke.
-
Market actionsWe're continuing to investigate and take action about the potential contamination of some saline products with Ralstonia pickettii. Read about a product recall and quarantines.
-
Market actionsBe alert to an issue affecting all units of the Scandinavian Total Ankle Replacement (STAR) Ankle Prosthesis supplied in the Australian market.
-
Safety alertsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.